Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Aldous

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Journal of Medicinal Chemistry|September 17, 1993
Mammalian topoisomerase II inhibitory activity of 1-cyclopropyl-6,8- difluoro-1,4-dihydro-7-(2,6-dimethyl-4-pyridinyl)-4-oxo-3-quinolinecarb oxylic acid and related derivativesM P Wentland, G Y Lesher, M Reuman, et al.
Journal of Medicinal Chemistry|April 14, 1995
Picornavirus inhibitors: trifluoromethyl substitution provides a global protective effect against hepatic metabolismG D Diana, P Rudewicz, D C Pevear, et al.
Journal of Medicinal Chemistry|July 7, 1995
Cyclic variations of 3-quinolinecarboxamides and effects on antiherpetic activityM P Wentland, J A Carlson, P H Dorff, et al.
Drug Design and Discovery|May 1, 1997
Antiviral properties of 3-quinolinecarboxamides: a series of novel non-nucleoside antiherpetic agentsM P Wentland, R B Perni, P H Dorff, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Journal of Medicinal Chemistry|September 17, 1993
Mammalian topoisomerase II inhibitory activity of 1-cyclopropyl-6,8- difluoro-1,4-dihydro-7-(2,6-dimethyl-4-pyridinyl)-4-oxo-3-quinolinecarb oxylic acid and related derivativesM P Wentland, G Y Lesher, M Reuman, et al.
Journal of Medicinal Chemistry|April 14, 1995
Picornavirus inhibitors: trifluoromethyl substitution provides a global protective effect against hepatic metabolismG D Diana, P Rudewicz, D C Pevear, et al.
Journal of Medicinal Chemistry|July 7, 1995
Cyclic variations of 3-quinolinecarboxamides and effects on antiherpetic activityM P Wentland, J A Carlson, P H Dorff, et al.
Drug Design and Discovery|May 1, 1997
Antiviral properties of 3-quinolinecarboxamides: a series of novel non-nucleoside antiherpetic agentsM P Wentland, R B Perni, P H Dorff, et al.
Pageof 6